In this report, Technavio covers the present scenario and growth prospects of the global active pharmaceutical ingredients (APIs) market for 2017-2021. The report also presents the vendor landscape and corresponding detailed profiles of the five prominent vendors operating in the market. The vendors have been selected based on their exports of APIs. We have considered 2016 as the base year and data for 2017-2021 are forecast. The numbers are rounded off in a few instances for calculation purposes and readability.

PART 01: Executive summary 6

PART 02: Scope of the report 18

Market overview 18

PART 03: Market research methodology 23

Research methodology 23

Economic indicators 23

PART 04: Introduction 24

Key market highlights 24

Overview 25

PART 05: Market landscape 26

Global APIs market 26

Five forces analysis 29

PART 06: Market segmentation by production process 30

Global APIs market by production process 30

Global synthetic APIs market 32

Global biotech APIs market 34

PART 07: Market segmentation by type 37

Global APIs market by type 37

PART 08: Market segmentation by vendor type 43

Global APIs market by vendor type 43

Global captive APIs market 44

Global merchant APIs market 46

PART 09: Geographic segmentation 48

Global APIs market by geography 48

APIs market in Americas 49

APIs market in APAC 52

APIs market in EMEA 54

Global APIs market by therapeutic areas 56

PART 10: Market drivers 57

Increasing incidence of age-related diseases globally 57

Strong focus on HPAPI 58

Measures against counterfeit drugs 58

PART 11: Impact of drivers 59

PART 12: Market challenges 60

Government regulations 60

Fierce competition among API manufacturers 61

Less R&D spending 61

Availability of counterfeit products 62

PART 13: Impact of drivers and challenges 63

PART 14: Market trends 64

Growing influence of key markets 64

Emergence of Africa 64

Increasing outsourcing activities 65

PART 15: Vendor landscape 66

Competitive scenario 66

Aurobindo Pharma 67

Cipla 68

Dr. Reddy’s Laboratories 69

Sun Pharmaceutical Industries Limited 71

Teva Pharmaceutical Industries 72

Other prominent vendors 73

PART 16: Appendix 75

List of abbreviations 75

PART 17: Explore Technavio 76